Cardinal Health Inc (CAH) is slightly overvalued and Cencora Inc (COR) is slightly overvalued.
Both trade above our estimate of their intrinsic value. CAH is the closer of the two: -9%, against -20% for COR.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.9% (average of 3 methods) values the shares at $203.47; the price of $222.04 is 9% above that value, and 80% of that value comes from beyond year five.
Leak Score 43/100 on 8 of 12 signals
Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $262.24; the price of $314.43 is 20% above that value, and 80% of that value comes from beyond year five.
Leak Score 57/100 on 10 of 12 signals
| Metric | CAH | COR |
|---|---|---|
| Verdict | Slightly overvalued | Slightly overvalued |
| Price | $222.04 | $314.43 |
| Intrinsic value | $203.47 | $262.24 |
| Margin of safety | -9% | -20% |
| Leak Score | 43/100 (8/12) | 57/100 (10/12) |
| Market cap | $51.6B | $60.0B |
| Revenue growth, 5 years | 9.4% | 11.1% |
| Operating margin | 1.3% | 1.3% |
| Net margin | 0.7% | 0.8% |
| Return on equity | — | 104.3% |
| Debt to equity | — | 3.84 |
| P/E | 30.7x | 23.4x |
| Forward P/E | 15.8x | 15.9x |
| P/B | — | 19.7x |
| Dividend yield | 0.9% | 0.8% |